Education
About Us
Working with TipRanks
Follow Us
Brainsway Ltd (BRSYF)
OTHER OTC:BRSYF
BRSYF Stock Chart & Stats
$7.81
$0.00(0.00%)
At close: 4:00 PM EST
$7.81
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$3.15 - $8.62
Previous CloseN/A
Volume2.42K
Average Volume (3M)0.00
Market Cap
$305.17M
Enterprise Value$599.47M
Total Cash (Recent Filing)$70.46M
Total Debt (Recent Filing)$6.75M
Price to Earnings (P/E)47.2
Beta-0.04
Next Earnings
Mar 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding39,128,260
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.33
Price to Book (P/B)2.56
Price to Sales (P/S)3.88
P/FCF Ratio24.49
Enterprise Value/Market Cap1.96
Enterprise Value/Revenue12.21
Enterprise Value/Gross Profit16.30
Enterprise Value/Ebitda65.77
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Brainsway News
BRSYF FAQ
What was Brainsway Ltd’s price range in the past 12 months?
Brainsway Ltd lowest stock price was $3.15 and its highest was $8.62 in the past 12 months.
What is Brainsway Ltd’s market cap?
Brainsway Ltd’s market cap is $305.17M.
When is Brainsway Ltd’s upcoming earnings report date?
Brainsway Ltd’s upcoming earnings report date is Mar 11, 2026 which is in 103 days.
How were Brainsway Ltd’s earnings last quarter?
Brainsway Ltd released its earnings results on Nov 11, 2025. The company reported $0.042 earnings per share for the quarter, beating the consensus estimate of N/A by $0.042.
Is Brainsway Ltd overvalued?
According to Wall Street analysts Brainsway Ltd’s price is currently Overvalued.
Does Brainsway Ltd pay dividends?
Brainsway Ltd does not currently pay dividends.
What is Brainsway Ltd’s EPS estimate?
Brainsway Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Brainsway Ltd have?
Brainsway Ltd has 39,128,260 shares outstanding.
What happened to Brainsway Ltd’s price movement after its last earnings report?
Brainsway Ltd reported an EPS of $0.042 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.5%.
Which hedge fund is a major shareholder of Brainsway Ltd?
Currently, no hedge funds are holding shares in BRSYF
Company Description
Brainsway Ltd
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
BRSYF Company Deck
BRSYF Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in revenue and system shipments, successful strategic investments, and improved financial guidance. However, there were increased operating expenses and delays in FDA clearance for a strategic partner's product. Overall, the positives significantly outweigh the negatives.View all BRSYF earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
0.29% Mutual Funds
0.24% Other Institutional Investors
99.09% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---